Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer

Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Carcinoma - the third leading cause of cancer-related deaths worldwide